ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1880

Rheumatoid Arthritis Mortality in the U.S. (1999–2020): A Decline in Rates, But Not in Disparities

Aziz-ur-Rahman Khalid1, Ghassan Makhoul2, Hasan Munshi2, Islam Rajab2, Emmanuel Olumuyide3, MD Walid Akram Hussain2, Aqsa Sorathia2, Elvira Assaf2, Amer Al Badawy2, John Salama2 and Robert Lahita4, 1St. Joseph's University Medical Center, wayne, 2St. Josephs University Medical Center, Paterson, 3Advocate Illinois Masonic Medical Center, Chicago, 4St. Josephs University Medical Center, Wayne, NJ

Meeting: ACR Convergence 2025

Keywords: Disparities, Epidemiology, Mortality, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1877–1913) Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease associated with increased morbidity and mortality. While treatments have evolved, national trends and sociodemographic disparities in RA-related mortality are poorly characterized. This study evaluates patterns in RA mortality over two decades, focusing on age, sex, race, geography, and place of death.

Methods: Mortality data for RA (ICD-10 code M06.9) from 1999–2020 were obtained from the CDC WONDER database. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated using census-adjusted estimates. Data were stratified by year, state, age group (10-year intervals), sex, race/ethnicity, Hispanic origin, urbanization level (2013 classification), and place of death.

Results: Between 1999 and 2020, there were 47,075 deaths related to rheumatoid arthritis (RA) in the United States. The age-adjusted mortality rate (AAMR) declined significantly from 0.87 per 100,000 in 1999 to 0.42 in 2020, representing a 51.7% decrease. Women experienced 2.4 times higher mortality than men, with an AAMR of 0.84 compared to 0.35. Mortality increased steeply with age, peaking at 10.1 per 100,000 among those aged 85 and older. By race and ethnicity, American Indian/Alaska Native individuals had the highest AAMR (1.07), followed by White (0.66), Black (0.49), and Asian/Pacific Islander (0.31); Hispanic individuals had an AAMR of 0.52. Urbanization patterns revealed the lowest AAMR in large central metro areas (0.52) and the highest in noncore rural areas (0.81). Geographic variation showed state AAMRs ranging from 0.52 in California to 1.27 in Montana, with elevated rates in older, less urbanized states. In terms of place of death, most occurred in inpatient settings (40.4%) or nursing homes (26.6%), followed by the decedent’s home (23.2%), hospice facilities (2.6%), outpatient/ER (3.6%), and other locations.

Conclusion: RA-related mortality in the U.S. declined significantly from 1999 to 2020. However, persistent disparities by age, sex, race, urbanization, and place of death underscore the need for targeted public health and clinical strategies to improve equity in RA outcomes and end-of-life care.

Supporting image 1Graphs showing state, demographic, gender, race, age groups, place of death, and yearly mortality from Rheumatoid Arthritis


Disclosures: A. Khalid: None; G. Makhoul: None; H. Munshi: None; I. Rajab: None; E. Olumuyide: None; M. Hussain: None; A. Sorathia: None; E. Assaf: None; A. Al Badawy: None; J. Salama: None; R. Lahita: None.

To cite this abstract in AMA style:

Khalid A, Makhoul G, Munshi H, Rajab I, Olumuyide E, Hussain M, Sorathia A, Assaf E, Al Badawy A, Salama J, Lahita R. Rheumatoid Arthritis Mortality in the U.S. (1999–2020): A Decline in Rates, But Not in Disparities [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/rheumatoid-arthritis-mortality-in-the-u-s-1999-2020-a-decline-in-rates-but-not-in-disparities/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-mortality-in-the-u-s-1999-2020-a-decline-in-rates-but-not-in-disparities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology